or Try an Advanced Search...

    Technical Analysis for CING - Cingulate Inc.

    Grade Last Price % Change Price Change
    F 3.85 -4.70% -0.19
    CING closed down 4.7 percent on Friday, November 1, 2024, on 18 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical CING trend table...
    Date Alert Name Type % Chg
    MACD Bearish Signal Line Cross Bearish 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Below Lower BB Weakness 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    BB Squeeze Ended Range Expansion -4.70%
    Lower Bollinger Band Touch Weakness -4.70%
    Oversold Stochastic Weakness -4.70%
    Bollinger Band Squeeze Range Contraction -9.62%
    Older End-of-Day Signals for CING ...

       Recent Intraday Alerts

    Alert Time
    Down 3% about 18 hours ago
    Fell Below Lower Bollinger Band about 21 hours ago
    Fell Below Previous Day's Low about 21 hours ago
    Down 2 % about 21 hours ago
    Down 1% about 21 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    CING Chart by TradingView
    Basic chart:

    Profile

    Cingulate Inc. is a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. With an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), Cingulate is identifying and evaluating additional therapeutic areas where PTR technology may be employed to develop future product candidates.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Pharmaceutical Products Neuroscience Attention Deficit Hyperactivity Disorder Amphetamine Methylphenidate Adhd Educational Psychology

    Is CING a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 8 Cingulate’s Shane Schaffer Joins Cast of Nationally Syndicated Big Biz Show
    Sep 27 Cingulate files to sell 1.5M shares of common stock for holders
    Sep 12 Cingulate Initiates Final Study for Lead ADHD Asset CTx-1301
    Aug 27 How Is The Market Feeling About Cingulate?
    Aug 26 CING: Initiating Coverage – Precision Timed Release Delivers Active-Day Coverage
    Aug 23 Cingulate Announces Adjournment of Special Meeting
    Aug 19 Top Midday Decliners
    Aug 19 Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Aug 19 Cingulate files to sell 1M shares of common stock for holders
    Aug 16 Top 5 Trending Stocks Of The Day: Amazon, AST Spacemobile, Cingulate, Applied Materials, And Tesla
    See more CING news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 152.4
    52 Week Low 1.8001
    Average Volume 378,956
    200-Day Moving Average 10.37
    50-Day Moving Average 5.44
    20-Day Moving Average 4.51
    10-Day Moving Average 4.47
    Average True Range 0.43
    RSI (14) 35.90
    ADX 10.04
    +DI 18.58
    -DI 27.26
    Chandelier Exit (Long, 3 ATRs) 3.94
    Chandelier Exit (Short, 3 ATRs) 5.10
    Upper Bollinger Bands 5.10
    Lower Bollinger Band 3.91
    Percent B (%b) -0.05
    BandWidth 26.23
    MACD Line -0.31
    MACD Signal Line -0.29
    MACD Histogram -0.0212
    Fundamentals Value
    Market Cap 10.88 Million
    Num Shares 2.83 Million
    EPS -31.20
    Price-to-Earnings (P/E) Ratio -0.12
    Price-to-Sales 0.00
    Price-to-Book 105.12
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 4.29
    Resistance 3 (R3) 4.32 4.21 4.21
    Resistance 2 (R2) 4.21 4.10 4.19 4.19
    Resistance 1 (R1) 4.03 4.03 3.98 4.00 4.16
    Pivot Point 3.92 3.92 3.89 3.90 3.92
    Support 1 (S1) 3.74 3.81 3.69 3.71 3.54
    Support 2 (S2) 3.63 3.74 3.61 3.51
    Support 3 (S3) 3.45 3.63 3.49
    Support 4 (S4) 3.42